Most Read Articles
Roshini Claire Anthony, 6 hours ago

Many pregnant women may not be getting adequate nutrition as advised by dietary guidelines, researchers of an Australian study found.

2 days ago
Misoprostol promotes the healing of small bowel ulcers in aspirin users whose condition is complicated by small bowel bleeding, reports a recent trial.
Yesterday
Atrial fibrillation (AF) appears to accelerate global cognitive decline and increase the risk of dementia in elderly adults, reports a recent study.
2 days ago
Concomitant use of psyllium fibres, taken before meals, appears to enhance the cholesterol-lowering effects of statins, according to a recent meta-analysis.

Aspirin use improves overall survival in patients with melanoma

09 May 2018

Postdiagnosis use of aspirin has been shown to provide a survival advantage in patients with melanoma, a recent study has shown.

An association existed between aspirin use and longer overall survival in univariate analysis and after controlling for age, sex, stage and treatment modalities (hazard ratio [HR], 0.58; 95 percent CI, 0.45–0.75). Aspirin use did not correlate with survival in patients with in situ and stage I melanoma, but it correlated with better survival in stages II (HR, 0.45; 0.24–0.82) and III (HR, 0.57; 0.34–0.96).

There was no statistical significance seen in stage IV patients (HR, 0.55; 0.27–1.13). Furthermore, melanoma was less likely to be diagnosed in stages III or IV among those using aspirin prior to diagnosis.

To determine whether aspirin confers longer survival in patients with melanoma, the authors conducted a retrospective cohort study of 1,522 patients at Indiana University Health who had melanoma diagnosed between 2000 and 2014, and were followed up through September 2016.

“Clinical trials investigating the therapeutic potential of aspirin are warranted,” the authors said, adding that the study was limited by its observational design.

In a previous meta-analysis, results support the therapeutic efficacy of adjuvant interferon alpha for the treatment of patients with high-risk cutaneous melanoma in terms of both disease-free survival and overall survival, to a lower extent. Additionally, interferon is valid as a reference treatment in trials investigating new therapeutic agents for the adjuvant treatment of this population. [Cochrane Database Syst Rev 2013;doi:10.1002/14651858.CD008955.pub2]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 6 hours ago

Many pregnant women may not be getting adequate nutrition as advised by dietary guidelines, researchers of an Australian study found.

2 days ago
Misoprostol promotes the healing of small bowel ulcers in aspirin users whose condition is complicated by small bowel bleeding, reports a recent trial.
Yesterday
Atrial fibrillation (AF) appears to accelerate global cognitive decline and increase the risk of dementia in elderly adults, reports a recent study.
2 days ago
Concomitant use of psyllium fibres, taken before meals, appears to enhance the cholesterol-lowering effects of statins, according to a recent meta-analysis.